by Genna Contino | Dec 5, 2024
As pharmaceutical giant Eli Lilly evolves its popular obesity and diabetes drug, the company has discovered positive side effects that could develop into spin-off medications. Users of GLP-1 drugs, which regulate blood sugar, appetite and digestion, have reported...
by Jonnathan Pulla Velecela | Nov 22, 2023
For almost two decades trade between the U.S. and Venezuela has been deteriorating. But that hasn’t deterred Chevron from staying in Venezuela and seeking long-term trade security. The latest announcement by the Treasury Department’s Office of Foreign Assets Control...
by Mrinalini Nayak | Oct 3, 2023
Nvidia announced three back-to-back enterprise deals with Indian conglomerates in September, deepening its commitment to the growing AI ecosystem in the South Asian Nation. The chipmaker will partner with Reliance Industries, Tata Group and Infosys to build an AI...
by Elizabeth Napolitano | Nov 2, 2022
A steep decline in cryptocurrency trading has plunged Coinbase Global Inc. (COIN) toward deep losses and analysts say there’s no easy fix to lift the company out of the red. Analysts have slashed their estimates for the crypto exchange just days before the company’s...
by By David Westenhaver | Oct 31, 2022
By David Westenhaver Facebook parent Meta Platforms Inc. reported skyrocketing expenses Wednesday as costly investments in the metaverse, artificial intelligence, servers, and data centers hurt the company’s bottom line. The social media company reported...
